In this session, you’ll learn how to:
-  Discuss the changed that occurred to Evaluation and Management services in 2021 and how those relate to the changes being made for 2023.
-  Identify areas that have been clarified or re-defined in the 2023 AMA change to alert physicians to the need for updating their knowledge base. 
-  Compare notes done in current Electronic Health System for Hospital services and show how they should look for 2023.

Jill M. Young, CPC, CEDC, CIMC, Principal Consultant, Young Medical Consulting, LLC

In this session, you’ll learn how to:
-  Understand how RPM devices work in clinical settings.
-  Recognize the importance of cybersecurity strategy in an RPM setting.
-  Data utilization in an RPM program.

Anthony J. Wehbe, DO, FACOI, Teaching Faculty, Internal Medicine, Rowan University School of Osteopathic Medicine

In this session, you’ll learn how to:
-  Discuss the stress physicians are under today.
-  Learn new ways to recognize stress, depression, anxiety. 
-  Learn how to help yourself, patients and staff treat stress factors.

Jeffrey M. Krepps, PhD, Director of Behavioral Health Education & Research, School of Osteopathic Medicine, Campbell University

Joanne K. Baker, DO, FACOI, Professor of Medicine, WMU Homer Stryker MD School of Medicine

Christine M. Samsa, DO, FACOI

David L. Tolentino, DO, FACOI, Associate Dean for Clinical Affairs, School of Osteopathic Medicine, Campbell University

In this session, you’ll learn how to:
-  Recognize and implement evidence-based screening strategies for better identifying COPD patient and associated comorbidities.
-  Select appropriate treatments to manage both COPD and comorbid conditions. 
-  Employ strategies for implementing GOLD guidelines in clinical practice.

Carol E. Ash, DO, FACOI, Chief Medical Officer, RWJ University Hospital Rahway

In this session, you’ll learn how to:
-  Understand translational biology of lipid management.
-  Understanding the treatment of lipid trials.
-  Discuss guideline recommendations.

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

In this session, you’ll learn how to:
-  Streamline care to support the best possible patient outcomes with heart failure (HF).
-  Increase use and awareness of drugs originally developed for treating Type 2 Diabetes however, now approved for reducing cardiovascular events and mortality in patients with HF, with our without Type 2 Diabetes. 
-  Better individualize HF care while continuing to increases the number of patients receiving guideline-directed medical therapy (GDMT).

Chad Link, DO, FACOI, Associate Clinical Instructor, Michigan State University College of Osteopathic Medicine

In this session, you’ll learn how to:
-  Overview of aortic stenosis and discuss ACC/AHA guidelines for patient selection and evaluation for transcatheter aortic valve replacement.
-  Overview of mitral valve disease and discuss ACC/AHA guidelines for patient selection and evaluation for transcatheter edge-to-edge repair of the mitral valve (TEER). 
-  Overview of atrial Fibrillation and discuss indications for left atrial appendage occlusion.

Troy L. Randle, DO, FACOI, Cardiology Fellowship Program Director, RowanSOM

In this session, you’ll learn how to:
-  Define Atrial Fibrillation and review AFib mechanism.
-  Review AFib health and economic bruden.
-  Discuss rhythm management strategies with focus on AFib ablation.

Ali H. Sheikh, DO, Assistant Professor of Medicine, Michigan State University - College of Human Medicine

In this session, you’ll learn how to:
-  Be ware of the impact of polypharmacy on patient health and well-being; Recognize the pill burden is a real issue for the elderly.
-  Understand supplements and herbal remedies that cna have side effects. To be aware of the impact of polypharmacy on patient health and well-being. 
-  Recognize that pill burden is a real issue for the elderly.
-  Supplemental and herbal remedies can have side effects too. Appreciate the importance of physical exam for appropriate testing.
-  A focus on physical exam has been deemed adequate in the ER in patient evaluation; Technological progress does not supersede clinical judgement.

Gerald W. Blackburn, DO, MACOI, Clinical Professor of Medicine, Michigan State University, College of Osteopathic Medicine

Annette T. Carron, DO, MACOI, Medical Director, Seasons Hospice Michigan

Pedro Espat, DO, FACOI, Department of Medicine, Sebastian River Medical Center

Roberta S. Rose, DO, Neurologist

In this session, you’ll learn how to:
-  Consider advantages and limitations of ICU vs Non-ICU settings in common clinical scenarios.
-  Approach level of care decisions from a shared decision making perspective among providers. 
-  Ensure patients and families understand motivations for level of care decisions.

John Dahdah, DO, Staff Physician, AdventHealth Tampa

In the keynote session, you’ll learn how to:
-  Start a conversation with anyone and build immediate rapport using the conversation blueprint
-  Start a conversation that breaks down barriers and social scripts, encouraging openness and trust; Understanding the power of psychological concept "The Swan Effect," and how it helps to stimulate connectedness through openness and vulnerability.

Robert L. DiGiovanni, DO, MACOI, President of the ACOI 2021-2022, Largo Medical Center

Susan M. Enright, DO, FACOI, Assistant Dean for Clerkship Education, MSUCOM

Vanessa Van Edwards, Founder of Science of People and Bestselling Author

In this session, you’ll learn how to:
-  Discuss new biologics and small molecule agents that have been FDA approved in the use of IBD over the past 2 years.
-  Discuss their respective mechanisms of action. 
-  Discuss appropriate session of when to use these new agents.

Susan Kais, MD, IBD Medical Director, Advent Health Orlando

In this session, you’ll learn how to:
-  Discuss advances in medical treatment of Hepatitis C.
-  Discuss advances in endoscopy.
-  Discuss advances in IBD treatment.

Michael Raphael, DO, Assistant Clinical Professor, MSU-COM, MSU-CHM

In this session, you’ll learn how to:
-  Learn to master diagnosis and treatment of GERD, nausea and vomiting.
-  Understand Pathophysiology of peptic ulcer disease and H Pylori, bloating and gallstone disease. 
-  Learn a systematic approach to the diagnosis and management of abdominal pain and the relationship to IBS - constipation or diarrhea predominance.

Charlene A. LePane, DO, FACOI, Gastroenterologist, AdventHealth

In this session, you’ll learn how to:
-  Diagnose pre-symptomatic Heart Failure (HF) at-risk patients; Distinguish HFeEF vs HFpEF.
-  Characterize the impact of SGLT2 inhibitors on HF risk among patients with Type 2 Diabetes. 
-  Discuss the putative mechanisms for cardio=protection associated with SGLT2 inhibitors.

Robert J. Chilton, DO, MACOI, Professor of Medicine, University of Texas Health Science Center

In this session, you’ll learn how to:
-  Identify patients at risk for fracture and develop a comfort level for interpreting diagnostic tools.
-  Identify effective treatment strategies based on mechanisms of action of the FDA approved medications for osteoporosis.
-  Develop an approach for long-term care, including frequency of monitoring, consideration of drug holidays and counseling regarding conservative measures to help decrease fracture risks.

Mark Vercel, DO, Assistant Professor of Clinical Medicine, University of South Dakota Sanford School of Medicine

In this session, you’ll learn how to:
-  Develop a rational approach to the diagnosis and evaluation of vasculitis and their mimics.
-  Differentiate potential vasculitis mimics based on the size of the blood vessel involved.
-  Identify the appropriate laboratory and radiographic evaluation in assessing for vasculitis and their common mimics.

Anisha Dua, MD, Director of the Vasculitis Center, Section of Rheumatology, Northwestern University Feinberg School of Medicine

In this session, you’ll learn how to:
-  Review the CASPAR criteria for psoriatic arthritis.
-  Describe the features of a typical psoriatic presentation.
-  Briefly discuss some of the most commonly used treatment options.

Arthur M. Mandelin, MD, PhD, Associate Professor of Medicine, Northwestern University Feinberg School of Medicine

In this session, you’ll learn how to:
-  Define an understand the causes of implicit bias.
-  Discuss the influence of stereotypes on implicit bias.
-  Explore the real world and healthcare implications of implicit bias.
-  Define and explore the terms belonging, breaking, bridging and othering.
-  Explore how bias leads to healthcare disparities.

Kellee L. Randle, DO, FACOI, CEO, Equity Ventures Plus, LLC

In this session, you’ll learn how to:
-  Pharmacologic approach to improve glycemic control in Type 2 diabetes.
-  Comparative data to improve glucose control with GLP receptors agonists and SGLT2 inhibitors. 
-  Discuss supporting data on cardiovascular risk reduction with both GLP receptor agonists and SGLT2 inhibitors.
-  Review data on the effectiveness of GLP receptor agonists and SGLT2 inhibitors on reducing obesity.
-  Learn new data on SGLT2 inhibitors and GLP receptor agonists pertaining to recusing renal end point.
-  Review data on the American Diabetes Association 2022 Guidelines and other organization’s statements pertaining to reducing cardiovascular and renal end points.

Jeffrey S. Freeman, DO, FACOI, Professor of Internal Medicine & Chairman of Division Endocrinology and Metabolism, Philadelphia College of Osteopathic Medicine

In this session, you’ll learn how to:
-  Discuss and understand symptoms that must be investigated in patients who have symptoms despite "well treated" hypothyroidism.
-  Discuss and understand alternative treatments of hypothyroidism symptoms.
-  Discuss and understand what can effect the thyroid blood tests and appropriate interpretation of the tests.

Jack L. Snitzer, DO, FACOI, Clinical Endocrinologist, TidalHealth Endocrinology

In this session, you’ll learn how to:
-  Expand our knowledge about implicit bias observed in the LGBTQ+ community in healthcare.
-  Solutions and strategies to help physicians reduce implicit bias and ultimately improve overall outcomes in healthcare. 
-  Acknowledge and learn about heuristics and how effective they can be.
-  Recognize the diffrences in implicit boas regarding race/culture.
-  Tips to work on Implicit bias regarding healthcare workers.

Nicola A. McLean, DO, FACOI, Hospitalist, Baptist Health

Berry Pierre, DO, FACOI, Clinical Assistant Professor, Orlando College of Osteopathic Medicine

Christina A. Stasiuk, DO, FACOI, ​Market Medical Executive Mid-Atlantic Region, Cigna

In this session, you’ll learn how to:
-  Understand the data backing oxygen therapy in chronic lung disease.
-  Understand the basics of home oxygen therapy. 
-  Understand the uses for portable vs stationary oxygen concentrators.

Mary R. Suchyta, DO, FACOI, Medical Director, Select Health

In this session, you’ll learn how to:
-  Understand the epidemiology and anatomy of Interstitial Pneumonitis variants and the initial diagnostics and basics of diagnosis.
-  Provide an overview of the 8 types of Interstitial Pneumonitis variants and the initial diagnostics and basics of diagnosis.
-  Introduce COVID-19 ILD.

David H. Lindner, DO, MBA, FACOI, FCCP, Section Chair, Pulmonary & Critical Care, NCH Health Care

In this session, you’ll learn how to:
-  Define and discuss the impact of inpatient providers on Utilization Management.
-  Define and discuss the impact of inpatient providers on CDI metrics, discharges, readmissions, and length of stay. 
-  Define the partnership between Care management and inpatient providers.

Ariana L. Peters, DO, FACOI, Medical Director, Care Management, Mayo Clinic Arizona

In this session, you’ll learn how to:
-  Discuss the role of patient in the medicines system and tactics to block or delay competition which keep drug prices higher for longer periods of time.
-  Discuss how through increased public participation in the patent system by affected stakeholders, including patient and healthcare professionals, critical reforms are possible.
-  Discuss possible reforms to update the outdated patent system.

Priti Krishtel, JD, Co-founder & Co-Executive Director, Initiative for Medicines, Access & Knowledge (I-MAK)

In this session, you’ll learn how to:
-  Define obesity in modern terms.
-  Learn options to treat obesity including medication, nutrition, movement, behavioral and surgical. 
-  Mention of myths & misconceptions about management of obesity.

U. Inge Ferguson, DO, FACOI, Medical Director, Behavioral Health Group

In this session, you’ll learn how to:
-  Understand current COVID-19 primary series and booster schedules.
-  Discuss strategies to overcome hurdles faced with VCOVID-19 Vaccines.
-  Gain a deeper understanding of current COVID-19 vaccine options to dispel COVID vaccine myths.

John A. Frith, DO, Allergy/Immunology Physician, Beaumont Hospital

In this session, you’ll learn how to:
-  Discuss the role of biologic medications in the armamentarium of the practicing allergist.
-  Identify key patient and disease characteristics to assist in individualizing therapy recommendations. 
-  Characterize key differences between biologics based on their targets pathways and mechanisms of action.

Bryan L. Martin, DO, MACOI, Emeritus Professor of Medicine, The Ohio State University

In this session, you’ll learn how to:
-  Identify the mechanism of action of COVID-19 vaccines.
-  Describe indications for COVID-19 vaccines. 
-  Review the adverse effects of tozinameran (BNT162b2) and mRNA-1273 SARS-Co-2.

MarkAlain Dery, DO, MPH, FACOI, Chief Innovation Officer, Access Health Louisiana

In this session, you’ll learn how to:
-  Discuss the current CDC COVID-19 Vaccine recommendations.
-  Review the most up-to-date available real-world effectiveness & safety data on real-world use of SARS CoV-2 vaccines. 
-  Discuss current/future SARS CoV-2 vaccine formulation and potential future vaccine approaches.

Liam R. Sullivan, DO, Associate Program Director Infectious Disease Fellowship, Spectrum Health-Michigan State University College of Human Medicine

Case Presentation and Original Research posters competition.

Carol I. Duffy, DO, FACOI

In this session, you’ll learn how:
-  To review and discuss updates on the treatment for first and recurrent episodes of clostridium difficile.
-  To discuss and review diagnosis and treatment guidelines for Lyme disease.
-  To review updates on the diagnosis and treatment of sexually transmitted infections including new HIV and PrEP therapeutics.

Mia A. Taormina, DO, FACOI, Chair, Department of Infectious Disease, Duly Health and Care

In this session, you’ll learn how to:
-  Discuss the epidemiology, clinical manifestations and treatment of monkeypox.
-  Define the risks and benefits of vaccination and/or treatment.
-  Discuss the current outbreak and to avoid spread of stigma surrounding this infection.

Patrick J. Kenney, DO, FACOI, Vice Chair, Department of Infectious Disease, Cleveland Clinic Florida

ACOI's 2022 Class of Fellows, Master Fellows and Award Recipients

Robert L. DiGiovanni, DO, MACOI, President of the ACOI 2021-2022, Largo Medical Center

Joanne Kaiser-Smith, DO, FACOI (President), Associate Dean

In this session, you’ll learn how to:
-  To identify dermatologic conditions that may manifest in hospitalized patients.
-  To layout a diagnostic and management approach to these derma logic conditions.
-  To provide treatment options to be used while the patient is hospitalized.

Heather Layher, DO, Dermatologist and Mohs Surgeon, North Idaho Dermatology

In this session, you’ll learn how to:
-  Define the Osteopathic Continuous Certification process.
-  Discuss the American Board of Internal Medicine Subspecialties. 
-  Review Questions from Audience.

J. Rico Blanco, Certification Director, American Osteopathic Board of Internal Medicine

In this session, you’ll learn how to:
-  Experience his journey as a physician through a career of challenges and obstacles.
-  Accept and internalize the ambiguities, challenges and opportunities for personal growth while pursuing a flourishing medical career.

Mark McLaughlin, MD, Founder, Princeton Brain, Spine, and Sports Medicine, LLC

In this session, you’ll learn how to:
-  Increase awareness of tickborne illnesses and to understand the impact of climate change on the ever expanding habitats where these vectors can be found.

Gerald W. Blackburn, DO, MACOI, Clinical Professor of Medicine, Michigan State University, College of Osteopathic Medicine

Bryan L. Martin, DO, MACOI, Emeritus Professor of Medicine, The Ohio State University

In this session, you’ll learn how to:
-  Understand the issues surrounding the medically fragile patients receiving home care.
-  Learn to help patients and families make decisions about treatment based on goals of care. 
-  Understand the transition to hospice and what level of care is appropriate.

Mitchell Forman, DO, FACOI, Dean Emeritus, Touro University, Nevada

Weldon (Don) Havins, MD, JD, LLM, Professor Emeritus, Touro University Nevada

In this session:
-  Audience will acknowledge importance of determining goad of care for patient with COVID19 and facing End-of-Life.
-  Participants will learn symptoms and COVID19 at End-of-Life and how to treat. 
-  Audience will become competent in recognizing moral distress.

Annette T. Carron, DO, MACOI, Medical Director, Seasons Hospice Michigan

In this session, you’ll learn how to:
-  Understand why caring for patients at end of life is so difficult.
-  List two reasons that complicate the resolution of the medically futile situation.
-  Describe the ethical difference of the end result of choosing to withhold vs withdraw treatment.

Karen J. Nichols, DO, MA, MACOI, Professor, Internal Medicine, Retired, Midwestern University/Chicago College of Osteopathic Medicine

In this session, you’ll learn how to:
-  Understand the issues surrounding medically fragile patients receiving home care.
-  Learn to help patients and families make decision about treatment bases on goals of care. 
-  Understand the transition to hospice and what level of care is appropriate and when.

Marianne M. Holler, DO, FACOI, Chief Medical Officer, VNA Health Group

In this session, you’ll learn how to:
-  Improve the care of patients with atrial fibrillation (AF) by more aggressively targeting modifiable risk factors that contribute to AF and AF burden.
-  Better individualize patient when considering the use of rate or rhythm control strategies, as well as the indications for ablation. 
-  Increase patient access to guideline-directed first-line use of direct-acting oral anticoagulants (DOACs) as first-line therapies to prevent stroke or systemic embolism associated with atrial fibrillation.

Chad Link, DO, FACOI, Associate Clinical Instructor, Michigan State University College of Osteopathic Medicine

In this session, you’ll learn:
-  The populations affected by variants of APOL1.
-  Inheritance of APOL1 variants.
-  Effect of APOL1 on kidney disease.

John E. Prior, DO, FACOI, Clinical Associate Professor of Medicine, The Geisinger Commonwealth School of Medicine

In this session, you’ll learn how to:
-  TBD
-  TBD 
-  TBD

Steven Sozio, MD, Associate Professor Medicine, Division of Nephrology, Johns Hopkins School of Medicine

In this session, you’ll learn how to:
-  Review dialysis access types, including the uncommon and last resort types.
-  Review dialysis access related complications including thrombosis and infections. 
-  Review dialysis related complications including mortality rates.

Viktoriya Yanchuk, DO, Teaching Faculty, Nephrology, Arrowhead Regional Medical Center

In this session, you’ll learn how to:
-  Discuss the staging and stratification of patients with myelodysplastic syndrome.
-  Discuss current standards of care for treating myelodysplastic syndrome for both low and high risk patients.

Gregory Harris, DO, FACOI, Hematology and Oncology, Harbin Clinic

In this session, you’ll learn how to:
-  Describe the services offered by a palliative care team as it relates to patients with cancer.
-  Understand crazy cycles and how they can influence decision-making and goals.
-  Recognize challenges that may impede implementation of supportive aspects of cancer care.

Kevin P. Hubbard, DO, MACOI, Clinical Professor of Medicine, University of Missouri - Kansas City School of Medicine

In this session, you’ll learn how to:
-  Define myeloproliferative disorders.
-  Know diseases included in the category.
-  Recognize clinical Signs and Symptoms.

Mary Jo Voelpel, DO, FACOI, Internal Medicine, Hematology/Oncology Specialist, Michigan State University

Robert L. DiGiovanni, DO, MACOI, President of the ACOI 2021-2022, Largo Medical Center

Joanne Kaiser-Smith, DO, FACOI (President), Associate Dean

Karen C. Caruth, MBA, Executive Director

In this session, you’ll learn how to:
-  Learn how to get the residency of your choice.
-  Understanding options in obtaining the fellowship you really want. 
-  What to expect on rotations.

Robert P. Aran, DO, Chief Fellow, Oklahoma State University (Tulsa)

In this session, you’ll learn:
-  The effect of compounding interest.
-  The need for budgeting and avoiding bad debt. 
-  The future needs in medicine.

Robert G. Good, DO, MACOI, Clinical Professor, Carle Illinois College of Medicine

Robert L. DiGiovanni, DO, MACOI, President of the ACOI 2021-2022, Largo Medical Center

MarkAlain Dery, DO, MPH, FACOI, Chief Innovation Officer, Access Health Louisiana

Samuel K. Snyder, DO, FACOI, Professor and Chair, Department of Internal Medicine, Nova Southeastern University

Amita Vasoya, DO, FACOI, Christiana Care Pulmonary Associates

In this session, you’ll learn:
-  Review strategies to pass the Boards.
-  3 Keys to passing the Boards. 
-  Discuss helpful resources.

Joshua Layher, DO, Internist, ST. LUKE'S HEALTH PARTNER